Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00528788 · ClinicalTrials.gov registry record · Phase 4
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00528788 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 24 participants.
The verdict
NCT00528788, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
Patients with chronic kidney disease and end stage renal disease have greater cardiovascular risk than the general population. Vitamin D analogues have been shown in observational studies to have mortality benefit for these patients. This study is designed to investigate doxercalciferol's effect on the vasculature (i.e. endothelial cell function) as a possible mechanism to explain the mortality benefit.
Interventions
- DRUG doxercalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00528788
The ClinicalTrials.gov registry entry for NCT00528788 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which doxercalciferol is the first listed.
NCT00528788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00528788 about?
NCT00528788 is a clinical study titled "How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis". Patients with chronic kidney disease and end stage renal disease have greater cardiovascular risk than the general population. Vitamin D analogues have been shown in observational studies to have mortality benefit for these patients. This study is designed to investigate doxercalciferol's effect on ...
What is the current status of trial NCT00528788?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2007-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00528788?
The interventions under investigation include: doxercalciferol (DRUG).
Who is sponsoring clinical trial NCT00528788?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.